Cenon-sur-Vienne (FR)
{name}
{subtitle}
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
city
~20 mi. (Lillette, France, +55 more cities)
facility
Centre Hospitalier Régional Universitaire de Lille (Adults and Pediatrics)
condition
Post-Transplant Lymphoproliferative Disorder
drug
tabelecleucel
drug type
cellular therapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~22 mi. (Poitiers, France, +145 more cities)
facility
CHU Poitiers ( Site 1109)
condition
Non-Small Cell Lung Carcinoma
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
city
~22 mi. (Poitiers, France, +105 more cities)
facility
CHU Poitiers ( Site 0612)
biomarker
ATM Loss, +62 more biomarkers
condition
Breast Carcinoma, +2 more conditions
drug
olaparib
drug type
targeted therapy
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma
city
~22 mi. (Poitiers, France, +54 more cities)
facility
CHU Poitier - La milétrie /ID# 229833
condition
Multiple Myeloma
drug
carfilzomib, +4 more drugs
drug type
chemotherapy, +3 more types
Evaluation of Pembrolizumab (MK-3475) or Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)
city
~22 mi. (Poitiers, France, +30 more cities)
facility
Centre Hospitalier Universitaire de Poitiers ( Site 0511)
biomarker
Deficient DNA Mismatch Repair (dMMR), +5 more biomarkers
condition
Colorectal Adenocarcinoma
drug
MK-1308A, +4 more drugs
drug type
immunotherapy
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~59 mi. (Tours, France, +197 more cities)
facility
CHRU Tours - Hopital Bretonneau /ID# 216186
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
condition
Acute Myeloid Leukemia
drug
azacitidine, +1 more drug
drug type
chemotherapy
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~59 mi. (Tours, France, +142 more cities)
facility
CHU Bretonneau
biomarker
del(11)(q10), +27 more biomarkers
condition
Myelofibrosis
drug
imetelstat, +1 more drug
drug type
targeted therapy